Company Search:
Advanced Search
Sponsored Links
Nel ASA Company Snapshot
Nel ASA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nel ASA with three other miscellaneous service companies in Europe: Oncodesign Sa of France (2016 sales of 11.20 million Euro [US$12.57 million] ), GW Pharmaceuticals PLC of the United Kingdom (£10.32 million [US$13.38 million] of which 63% was Commercial), and Selvita SA which is based in Poland (48.13 million Polish New Zlotys [US$12.92 million] of which 67% was Services).

Sales Analysis. Nel ASA reported sales of NOK 114.48 million (US$13.74 million) for the year ending December of 2016. This represents an increase of 14.6% versus 2015, when the company's sales were NOK 99.93 million. This was the fourth straight year of sales growth at Nel ASA.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Nel ASA
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): 2.19
(Figures in Norwegian Kroner)
1 Week 5.8%   13 Weeks -3.1%  
4 Weeks -25.0%   52 Weeks -12.4%  
Nel ASA Key Data:
  Ticker: NEL Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 114,478,693
(Year Ending Jan 2017).
Employees: 75
  Currency: Norwegian Kroner Market Cap: 1,634,403,824
  Fiscal Yr Ends: December Shares Outstanding: 746,303,116
  Share Type: Ordinaere Aksje Closely Held Shares: 268,953,657
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.